{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T04:02:33Z","timestamp":1773892953868,"version":"3.50.1"},"reference-count":111,"publisher":"Georg Thieme Verlag KG","issue":"08","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug Res (Stuttg)"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Prostate carcinoma is typical cancer. It is the second most common cancer globally. The estimated new cases in 2020 was 191\u2009930 and estimated deaths was 33\u2009330. Age, family history, &amp; genetic factors are major factors that drive prostate cancer. Although, for treating metastatic disease, the major therapies available are radiation,bisphosphonate, and palliative chemotherapy. But the major drawback is therapy is disease-driven and later becomes metastatic and requires treatment. The ability to revolutionize cancer treatment by major targeting vehicles via the exploration of nanoemulsion suggests a potential for cancer treatment. The unique property of a biphasic liquid dosage form called nanoemulsion to reach leaky tumor vasculature is due to its nano-meter oil-droplet size of 20\u2013200\u2009nm. Recent reporting on nanoemulsions disclose their embracing and lay alternative for re-purposing herbal and synthetic drugs and their combination especially for targeting prostate cancer formulating an obtainable nanomedicine. So, this article emphasizes the use of nanoemulsions incorporating therapeutic agents for successful and targeted delivery for prostate cancer.<\/jats:p>","DOI":"10.1055\/a-1518-6606","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T22:46:32Z","timestamp":1624401992000},"page":"417-428","source":"Crossref","is-referenced-by-count":16,"title":["Exploring Nanoemulsions for Prostate Cancer Therapy"],"prefix":"10.1055","volume":"71","author":[{"given":"Sushmita","family":"Srivastava","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Faheem","family":"Haider","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Afroz","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Arif","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asad","family":"Ali","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Integral University, Lucknow, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"ref1","first-page":"155","article-title":"Immunology and immunopathology. Lecture course, Chisinau, uasm","volume":"4","author":"R Golban","year":"2015","journal-title":"Moodle. md, UASM"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"J Ferlay","year":"2018","journal-title":"Int J Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/smll.200600427","article-title":"Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies","volume":"3","author":"V Kattumuri","year":"2007","journal-title":"Small."},{"key":"ref4","first-page":"124","article-title":"Advanced nanomedicine: Present contributions and future expectations","volume":"1","author":"D K Kapoor","year":"2013","journal-title":"American J Phytomed Clin Therapeutics"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/smll.200800525","article-title":"Soybeans as a phytochemical reservoir for the production and stabilization of biocompatible gold nanoparticles","volume":"4","author":"R Shukla","year":"2008","journal-title":"Small."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"9835","DOI":"10.1039\/C5AY02014J","article-title":"A systematic comparison of different techniques to determine the zeta potential of silica nanoparticles in biological medium","volume":"7","author":"A Sikora","year":"2015","journal-title":"Analytical Methods"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10585-016-9816-8","article-title":"Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes","volume":"33","author":"O Golubnitschaja","year":"2016","journal-title":"Clinical & Experimental Metastasis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s13167-017-0086-6","article-title":"Feeling cold and other underestimated symptoms in breast cancer: Anecdotes or individual profiles for advanced patient stratification?","volume":"8","author":"O Golubnitschaja","year":"2017","journal-title":"EPMA Journal"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13167-017-0089-3","article-title":"Breast cancer and Flammer syndrome: Any symptoms in common for prediction, prevention and personalised medical approach?","volume":"8","author":"P Zubor","year":"2017","journal-title":"EPMA Journal"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s13167-018-0131-0","article-title":"Premenopausal breast cancer: potential clinical utility of a multi-omics based machine learning approach for patient stratification","volume":"9","author":"H Fr\u00f6hlich","year":"2018","journal-title":"EPMA Journal"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.2217\/fon-2018-0061","article-title":"miRNA in a multiomic context for diagnosis, treatment monitoring and personalized management of metastatic breast cancer","volume":"14","author":"P Zubor","year":"2018","journal-title":"Future Oncology"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"F Bray","year":"2018","journal-title":"CA: A cancer journal for clinicians"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mnfr.200700511","article-title":"International epidemiology of prostate cancer: Geographical distribution and secular trends","volume":"53","author":"P D Baade","year":"2009","journal-title":"Molecular Nutrition & Food Research"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"R Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.5489\/cuaj.4888","article-title":"Canadian Urological Association recommendations on prostate cancer screening and early diagnosis","volume":"11","author":"R A Rendon","year":"2017","journal-title":"Canadian Urological Association Journal"},{"key":"ref23","volume-title":"Global cancer observatory: cancer tomorrow","author":"JE M Ferlay"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3322\/canjclin.22.4.232","article-title":"Studies on prostatic cancer. I. The effect of castration, of estrogen and androgen injection on serum phosphatases in metastatic carcinoma of the prostate","volume":"22","author":"C Huggins","year":"1972","journal-title":"CA Cancer J Clin"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration, resistant prostate cancer population: a systematic review","volume":"65","author":"M Kirby","year":"2011","journal-title":"International Journal of Clinical Practice"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3322\/caac.21208","article-title":"Cancer statistics, 2014","volume":"64","author":"R Siegel","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.ejca.2012.12.027","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012","volume":"49","author":"J Ferlay","year":"2013","journal-title":"Eur J Cancer"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/cncr.20408","article-title":"Human prostate cancer risk factors","volume":"101","author":"D G Bostwick","year":"2004","journal-title":"Cancer"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1464-410X.2004.04795.x","article-title":"Diet, anthropometric measures and prostate cancer risk: a review of prospective cohort and intervention studies","volume":"93","author":"P C Dagnelie","year":"2004","journal-title":"BJU Int"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"793","DOI":"10.7326\/0003-4819-118-10-199305150-00007","article-title":"Risk factors for prostate cancer","volume":"118","author":"K J Pienta","year":"1993","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.18632\/oncotarget.2953","article-title":"Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression","volume":"6","author":"A P Rybak","year":"2015","journal-title":"Oncotarget"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/mp700113r","article-title":"Bioavailability of curcumin: problems and promises","volume":"4","author":"P Anand","year":"2007","journal-title":"Molecular Pharmaceutics"},{"key":"ref34","first-page":"pp. 453","volume-title":"Pharmacokinetics and pharmacodynamics of curcumin","author":"R A Sharma","year":"2007"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ejps.2009.02.019","article-title":"Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer","volume":"37","author":"J Shaikh","year":"2009","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S2221-1691(12)60241-X","article-title":"Preparation and characterization of curcumin\u2013piperine dual drug loaded nanoparticles","volume":"2","author":"C Moorthi","year":"2012","journal-title":"Asian Pacific Journal of Tropical Biomedicine"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1039\/c1fo10053j","article-title":"Structure of modified \u03b5-polylysine micelles and their application in improving cellular antioxidant activity of curcuminoids","volume":"2","author":"H Yu","year":"2011","journal-title":"Food & Function"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"5373","DOI":"10.1021\/jf300609p","article-title":"Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions","volume":"60","author":"H Yu","year":"2012","journal-title":"Journal of Agricultural and Food Chemistry"},{"key":"ref39","first-page":"2","article-title":"Recent Progress in Antitumoral Nanotechnology","volume":"1","author":"F B M\u00e9ndez","year":"2015","journal-title":"Int J Nanoparticles Nanotech"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.pharmthera.2006.05.006","article-title":"Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery","volume":"112","author":"N Nishiyama","year":"2006","journal-title":"Pharmacology & Therapeutics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-006-9132-0","article-title":"Micellar nanocarriers: pharmaceutical perspectives","volume":"24","author":"V P Torchilin","year":"2007","journal-title":"Pharmaceutical Research"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ijpharm.2010.07.021","article-title":"Transferrin mediated solid lipid nanoparticles containing curcumin: enhanced in vitro anticancer activity by induction of apoptosis","volume":"398","author":"R S Mulik","year":"2010","journal-title":"International Journal of Pharmaceutics"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/j.biomaterials.2011.01.073","volume":"32","author":"E B Anat","year":"2011","journal-title":"Biomater"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2009.08.011","article-title":"Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel","volume":"140","author":"F Danhier","year":"2009","journal-title":"Journal of Controlled Release"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2008.04.027","article-title":"Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion","volume":"360","author":"S Ganta","year":"2008","journal-title":"Int J Pharm"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/10611860903244199","article-title":"Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion","volume":"18","author":"S Ganta","year":"2010","journal-title":"Journal of Drug Targeting"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s11095-012-0793-6","article-title":"Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells","volume":"29","author":"M Talekar","year":"2012","journal-title":"Pharm Res"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/jps.20249","article-title":"Pharmacokinetics and tissue distribution of etoposide delivered in parenteral emulsion","volume":"94","author":"R R Patlolla","year":"2005","journal-title":"J Pharm Sci"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1166\/jbn.2006.038","article-title":"Preparation and in vitro characterization of multifunctional nanoemulsions for simultaneous MR imaging and targeted drug delivery","volume":"2","author":"S Tiwari","year":"2006","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1021\/nn103336a","article-title":"Multifunctional nanoemulsion platform for imaging guided therapy evaluated in experimental cancer","volume":"5","author":"A Gianella","year":"2011","journal-title":"ACS Nano"},{"key":"ref51","first-page":"848043","article-title":"Formulation strategies to improve the bioavailability of poorly absorbed drugs with special emphasis on self-emulsifying systems","volume":"2013","author":"S Gupta","year":"2013","journal-title":"ISRN Pharm"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2174\/156720111795767906","article-title":"Oral lipid based drug delivery system: formulation, characterization and application: a review","volume":"8","author":"A Rahman","year":"2011","journal-title":"Curr Drug Deliv"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"A Jemal","year":"2011","journal-title":"CA Cancer J. Clin"},{"key":"ref54","first-page":"105","article-title":"Stem cells, cancer, and cancer stem cells","volume":"414","author":"T Reya","year":"2001","journal-title":"Nat. Cell Boil"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/cjpp-2016-0079","article-title":"The role of cancer stem cells in tumor heterogeneity and resistance to therapy","volume":"95","author":"R Murali","year":"2017","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref56","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2017.08.004","article-title":"Formulation of a Novel Taxoid DHA-SBT-1214 Inhibits Prostate Cancer Stem Cell-Induced Tumor Growth","volume":"406","author":"G Ahmad","year":"2017","journal-title":"Cancer Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1073\/pnas.1111840108","article-title":"Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance","volume":"108","author":"J-P Gillet","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/10408398.2011.559558","article-title":"Food-grade nanoemulsions: formulation, fabrication, properties, performance, biological fate, and potential toxicity","volume":"51","author":"D J McClements","year":"2011","journal-title":"Critical Reviews in Food Science and Nutrition"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.postharvbio.2015.03.009","article-title":"Use of antimicrobial nanoemulsions as edible coatings: Impact on safety and quality attributes of fresh-cut Fuji apples","volume":"105","author":"L Salvia-Trujillo","year":"2015","journal-title":"Postharvest Biology and Technology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.cis.2003.10.023","article-title":"Formation and stability of nano-emulsions","volume":"108\u2013109","author":"T Tadros","year":"2004","journal-title":"Advances in Colloid and Interface Science"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"12758","DOI":"10.1021\/la801685v","article-title":"Impact of oil type on nanoemulsion formation and Ostwald ripening stability","volume":"24","author":"T Wooster","year":"2008","journal-title":"Langmuir"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1039\/C2SM06903B","article-title":"Nanoemulsions versus microemulsions: terminology, differences and similarities","volume":"8","author":"D J McClements","year":"2012","journal-title":"Soft Matter"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1208\/s12249-014-0088-9","article-title":"Nanoemulsions in Translational Research\u2014Opportunities and Challenges in Targeted Cancer Therapy","volume":"15","author":"S Ganta","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref64","first-page":"665","article-title":"Studies of Formation and Interface of Oil-Water Microemulsion","volume":"30","author":"H J Gi","year":"1992","journal-title":"Chin. J. Phys"},{"key":"ref65","first-page":"1","article-title":"Nanoemulsions: As modified drug delivery tool","volume":"2","author":"V Devarajan","year":"2011","journal-title":"Pharm. Glob"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5530\/srp.2017.1.8","article-title":"Emulsion micro emulsion and nano emulsion: A review","volume":"8","author":"S N Kale","year":"2016","journal-title":"Syst Rev Pharm"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"F Danhier","year":"2010","journal-title":"J Control Release"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molliq.2015.11.050","article-title":"Critical steps and energetics involved in a successful development of a stable nanoemulsion","volume":"214","author":"A Qadir","year":"2016","journal-title":"J Mol Liq"},{"key":"ref69","first-page":"42","article-title":"A Review on Formulation and Characterization of Nanoemulsion","volume":"11","author":"N Amin","year":"2019","journal-title":"Int J Curr Pharm Res"},{"key":"ref70","first-page":"309","article-title":"Effect of carrier oil and co-solvent on the formation of clove oil nanoemulsion by phase inversion technique","author":"S Yuliani","year":"2019","journal-title":"IOP Conf. Ser. Earth Environ Sci."},{"key":"ref71","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1208\/s12249-014-0088-9","article-title":"Nanoemulsions in Translational Research\u2014Opportunities and Challenges in Targeted Cancer Therapy","volume":"15","author":"S Ganta","year":"2014","journal-title":"AAPS PharmSciTech"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"2826e41","DOI":"10.1039\/C5SM02958A","article-title":"Nanoemulsions: formation, properties and applications","volume":"12","author":"A Gupta","year":"2016","journal-title":"Soft Matter"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jconrel.2008.09.074","article-title":"Drug targeting and tumor heterogeneity","volume":"133","author":"Y H Bae","year":"2009","journal-title":"J Control Release"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"D Peer","year":"2007","journal-title":"Nat Nanotechnol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1023\/A:1016095415849","article-title":"Fat emulsions based on structured lipids (1, 3-specific triglycerides): an investigation of the in vivo fate","volume":"13","author":"M Hedeman","year":"1996","journal-title":"Pharmaceutical Research"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.molliq.2018.01.123","article-title":"Optimization of rivastigmine nanoemulsion for enhanced brain delivery: in-vivo and toxicity evaluation","volume":"255","author":"M F Haider","year":"2018","journal-title":"J Molecular Liquids"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1166\/jbn.2006.038","article-title":"Preparation and in vitro characterization of multifunctional nanoemulsions for simultaneous MR imaging and targeted drug delivery","volume":"2","author":"S Tiwari","year":"2006","journal-title":"J Biomed Nanotechnol"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2012.10.015","article-title":"Development of O\/W nanoemulsions for ophthalmic administration of timolol","volume":"440","author":"M Gallarate","year":"2013","journal-title":"Int J Pharm"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.3109\/03639045.2013.814065","article-title":"Nebulized oil-in-water nanoemulsion mists for pulmonary delivery: development, physico-chemical characterization and in vitro evaluation","volume":"40","author":"J Nesamony","year":"2013","journal-title":"Drug Dev Ind Pharm"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/sj.jid.5700485","article-title":"Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats","volume":"127","author":"S Khandavilli","year":"2007","journal-title":"J Investig Dermatol"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s13205-014-0214-0","article-title":"Nanoemulsion: An advanced mode of drug delivery system","volume":"5","author":"M Jaiswal","year":"2015","journal-title":"3 Biotech"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/21691401.2017.1324465","article-title":"Silmayrinnanoemulsion against human hepatocellular carcinoma: development and optimization","volume":"46","author":"U Ahmad","year":"2018","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/02652030701744538","article-title":"Applications and implications of nanotechnologies for the food sector","volume":"25","author":"Q Chaudhry","year":"2008","journal-title":"Food additives and contaminants"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11051-008-9446-4","article-title":"Characterization of size, surface \u00a8 charge, and agglomeration state of nanoparticle dispersions for toxicological studies","volume":"11","author":"JG Jiang","year":"2009","journal-title":"Journal of Nanoparticle Research"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2010.06.010","article-title":"Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (-)-epigallocatechin gallate","volume":"41","author":"A Dube","year":"2010","journal-title":"Eur J Pharm Sci"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ptr.2899","article-title":"Studies on the effects of oral administration of nutrient mixture, quercetin and red onions on the bioavailability of epigallocatechin gallate from green tea extract","volume":"24","author":"A Kale","year":"2010","journal-title":"Phytother Res"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.foodres.2013.07.009","article-title":"Oxidative stability and rheological properties of nanoemulsion with ultrasonic extracted green tea infusion","volume":"54","author":"A Lante","year":"2013","journal-title":"Food Res Int"},{"key":"ref88","first-page":"186","article-title":"Nanoemulsified green tea extract shows improved hypocholesterolemic effects in C57BL\/6 mice","volume":"23","author":"Y J Kim","year":"2012","journal-title":"J NutrBiochem"},{"key":"ref89","first-page":"1907","article-title":"Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3","volume":"11","author":"Y J Tsai","year":"2016","journal-title":"International Journal of Nanomedicine"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1158\/0008-5472.CAN-05-3636","article-title":"Targeting multiple signaling pathways by green tea polyphenol (\u2212)-epigallocatechin-3-gallate","volume":"66","author":"N Khan","year":"2006","journal-title":"Cancer Res"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.colsurfb.2013.06.032","article-title":"Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailability","volume":"111","author":"J Sun","year":"2013","journal-title":"Colloids Surf B Biointerfaces"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-3155-5-3","article-title":"Polymeric nanoparticle-encapsulated curcumin (\u2018\u2018nanocurcumin\u2019\u2019): a novel strategy for human cancer therapy","volume":"5","author":"S Bisht","year":"2007","journal-title":"J Nanobiotechnol"},{"key":"ref93","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1477-3155-11-37","article-title":"Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin","volume":"11","author":"M H Ucisik","year":"2013","journal-title":"J Nanobiotechnol"},{"key":"ref94","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11596-017-1742-8","article-title":"Therapeutic effects of curcumin nanoemulsions on prostate cancer","volume":"37","author":"Y B Guan","year":"2017","journal-title":"Journal of Huazhong University of Science and Technology [Medical Sciences]"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12263-009-0152-3","article-title":"Chemopreventive potential of curcumin in prostate cancer","volume":"5","author":"M H Teiten","year":"2010","journal-title":"Genes & Nutrition"},{"key":"ref96","first-page":"2018","article-title":"Plumbagin-loaded nanoemulsion drug delivery formulation and evaluation of antiproliferative effect on prostate cancer cells","volume":"11","author":"A Chrastina","year":"2018","journal-title":"BioMed Research International"},{"key":"ref97","first-page":"pp. 229","volume-title":"Plumbagin and its role in chronic diseases","author":"P Panichayupakaranant","year":"2016"},{"key":"ref98","first-page":"810","article-title":"Development of a new rutinnanoemulsion and its application on prostate carcinoma PC3 cell line","volume":"16","author":"M Ahmad","year":"2017","journal-title":"Excli Journal"},{"key":"ref99","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1158\/0008-5472.CAN-06-2731","article-title":"Anti-HER2 cationic immunoemulsion as a potential targeted drug delivery system for the treatment of prostate cancer","volume":"67","author":"D Goldstein","year":"2007","journal-title":"Cancer Research"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1158\/1535-7163.MCT-13-0405","article-title":"Prostate cancer cell response to paclitaxel is affected by abnormally expressed securin PTTG1","volume":"13","author":"C Castilla","year":"2014","journal-title":"Molecular Cancer Therapeutics"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<499::AID-BDD37>3.0.CO;2-J","article-title":"The effect of food on the pharmacokinetics of the bicalutamide (\u2018Casodex\u2019) enantiomers","volume":"18","author":"I D Cockshott","year":"1997","journal-title":"Biopharm. Drug Dispos."},{"key":"ref102","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1586\/14737140.4.1.37","article-title":"Bicalutamide (Casodex) in the treatment of prostate cancer","volume":"4","author":"Y Fradet","year":"2004","journal-title":"Expert Rev. Anticancer Ther"},{"key":"ref103","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3816\/CGC.2004.n.002","article-title":"An evaluation of bicalutamide in the treatment of prostate cancer","volume":"2","author":"P F Schellhammer","year":"2004","journal-title":"Clin. Prostate Cancer"},{"key":"ref104","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/157341312800167579","article-title":"Effect of bovine serum albumin on the stability of bicalutamide-encapsulated lipid nano-emulsion in bovine serum","volume":"8","author":"S Takegami","year":"2012","journal-title":"Current Nanoscience"},{"key":"ref105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/pcan.2008.23","article-title":"Differential mechanisms of bicalutamide-induced apoptosis in prostate cell lines","volume":"12","author":"M S Floyd","year":"2009","journal-title":"Prostate Cancer and Prostatic Diseases"},{"key":"ref106","first-page":"1125","article-title":"Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy","volume":"13","author":"M S Ali","year":"2014","journal-title":"Iranian Journal of Pharmaceutical Research: IJPR"},{"key":"ref107","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/j.1939-4640.2004.tb03166.x","article-title":"Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride","volume":"25","author":"L J Schmidt","year":"2004","journal-title":"Journal of Andrology"},{"key":"ref109","first-page":"3864","article-title":"Effect of docetaxel on the regulation of proliferation and apoptosis of human prostate cancer cells","volume":"19","author":"C Yang","year":"2019","journal-title":"Molecular Medicine Reports"},{"key":"ref110","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1073\/pnas.1600420113","article-title":"Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression","volume":"113","author":"K Komura","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/pharmaceutics11120640","article-title":"Attenuation of Benign Prostatic Hyperplasia by Optimized Tadalafil Loaded Pumpkin Seed Oil-Based Self Nanoemulsion: In Vitro and In Vivo Evaluation","volume":"11","author":"N A Alhakamy","year":"2019","journal-title":"Pharmaceutics."},{"key":"ref112","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1166\/jbn.2014.1912","article-title":"Nanoemulsion based concomitant delivery of curcumin and etoposide: Impact on cross talk between prostate cancer cells and osteoblast during metastasis","volume":"10","author":"P Shukla","year":"2014","journal-title":"Journal of Biomedical Nanotechnology"},{"key":"ref113","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/01635580903441238","article-title":"Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria","volume":"62","author":"A L Hilchie","year":"2010","journal-title":"Nutrition and cancer"},{"key":"ref114","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.1038\/sj.onc.1204997","article-title":"Curcumin downregulates cell survival mechanisms in human prostate cancer cell lines","volume":"20","author":"A Mukhopadhyay","year":"2001","journal-title":"Oncogene"},{"key":"ref115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jddst.2018.07.013","article-title":"A synergistic nanoformulation of babassu and copaiba oils as natural alternative for prevention of benign prostatic hyperplasia","volume":"47","author":"L C de Abreu","year":"2018","journal-title":"Journal of Drug Delivery Science and Technology"},{"key":"ref116","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.7150\/thno.4525","article-title":"Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery","volume":"2","author":"Y Guo","year":"2012","journal-title":"Theranostics."},{"key":"ref117","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5530\/fra.2020.1.7","article-title":"Promising inhibitor against mitogen-activated protein kinase-dependent inflammation and ameliorates nicotine induced-lung toxicity in rats","volume":"10","author":"F T Mohamed","year":"2020","journal-title":"Free Radicals and Antioxidants"},{"key":"ref118","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0928-0987(00)00167-6","article-title":"Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and \u2018self-microemulsifying\u2019drug delivery systems","volume":"11","author":"C W Pouton","year":"2000","journal-title":"European Journal of Pharmaceutical Sciences"},{"key":"ref119","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.31142\/ijtsrd23233","article-title":"A Novel Approach on Thalidomide and their Analogues with their Therapeutic uses and Clinical Application","volume":"3","author":"R S Kushwaha","year":"2019","journal-title":"IJTSRD"},{"key":"ref120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ijpharm.2014.07.022","article-title":"Topotecan tamoxifen duple PLGA polymeric nanoparticles: Investigation of in vitro, in vivo and cellular uptake potential","volume":"473","author":"T Khuroo","year":"2014","journal-title":"Int J Pharmaceutics"}],"container-title":["Drug Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1518-6606.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T01:03:35Z","timestamp":1632359015000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1518-6606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":111,"journal-issue":{"issue":"08","published-online":{"date-parts":[[2021,9,22]]},"published-print":{"date-parts":[[2021,10]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1518-6606","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2194-9379","2194-9387"],"issn-type":[{"value":"2194-9379","type":"print"},{"value":"2194-9387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]}}}